News
L-Leucine (amount not specified): An essential amino acid, L-leucine helps preserve lean muscle mass during weight loss, ...
Dr. Thanh Nguyen is a board-certified Internal Medicine physician practicing in Phoenix and Mesa, Arizona. He specializes in ...
SANTA YNEZ, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Raw Garden, California’s leading Clean Green-certified cannabis ...
CHARLOTTE, N.C., July 02, 2025 (GLOBE NEWSWIRE) -- Hemp Hop has announced the launch of 2 new high-THCa strains - London ...
Basel, July 03, 2025 – Novartis today announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis ...
The Transaction will be implemented by way of a plan of arrangement under the Business Corporations Act (Québec) and is expected to close during the Company’s fourth quarter ending November 30, 2025, ...
This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...
Building on its acquisition of 15 mining permits located at the Fola Mine Complex in March 2025, the Company has purchased two additional mining permits (“Purchased Permits”) at the site with an ...
About Syndax Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj ® (revumenib), an ...
Spartan Capital Securities, LLC acted as exclusive placement agent for the private placement. TroyGould PC acted as counsel to the Company. Kaufman & Canoles, P.C. acted as counsel to Spartan Capital ...
The stock options are subject to the terms and conditions of Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan, as well as the terms and conditions of the stock option agreement covering the ...
Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results